Search Results - "Naranda, Tatjana"

Refine Results
  1. 1

    A Randomized Trial Assessing the Safety, Pharmacokinetics, and Efficacy During Morning Off of AZ‐009 by Thijssen, Eva, Heijer, Jonas, Puibert, David, Moss, Laurence, Lei, Mingzu, Hasegawa, David, Keum, Kyo, Mochel, Ken, Ezzeldin Sharaf, Mohammed, Alfredson, Tom, Zeng, Wenxiang, Brummelen, Emilie, Naranda, Tatjana, Groeneveld, Geert Jan

    Published in Movement disorders (01-04-2022)
    “…ABSTRACT Background Inhalation of apomorphine could be a faster‐acting and more user‐friendly alternative to subcutaneous injection for treating off periods in…”
    Get full text
    Journal Article
  2. 2

    Activation of Erythropoietin Receptor in the Absence of Hormone by a Peptide That Binds to a Domain Different from the Hormone Binding Site by Naranda, Tatjana, Wong, Kenneth, Kaufman, R. Ilene, Goldstein, Avram, Olsson, Lennart

    “…Applying a homology search method previously described, we identified a sequence in the extracellular dimerization site of the erythropoietin receptor, distant…”
    Get full text
    Journal Article
  3. 3

    SUI1/p16 is required for the activity of eukaryotic translation initiation factor 3 in Saccharomyces cerevisiae by Naranda, Tatjana, Macmillan, Susan E., Donahue, Thomas F., Hershey, John W. B.

    Published in Molecular and Cellular Biology (01-05-1996)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  4. 4

    Safety and pharmacokinetics of multiple dosing with inhalable apomorphine (AZ-009), and its efficacy in a randomized crossover study in Parkinson's disease patients by Thijssen, Eva, den Heijer, Jonas M., Puibert, David, van Brummelen, Emilie M.J., Naranda, Tatjana, Groeneveld, Geert Jan

    Published in Parkinsonism & related disorders (01-04-2022)
    “…Apomorphine is used to treat OFF periods in Parkinson's disease (PD) patients. AZ-009 is a novel apomorphine formulation that delivers a thermally-generated…”
    Get full text
    Journal Article
  5. 5

    A Peptide Derived from an Extracellular Domain Selectively Inhibits Receptor Internalization: Target Sequences on Insulin and Insulin-Like Growth Factor 1 Receptors by Naranda, Tatjana, Goldstein, Avram, Olsson, Lennart

    “…Certain peptides derived from the α 1 domain of the major histocompatibility class I antigen complex (MHC-I) inhibit receptor internalization, increasing the…”
    Get full text
    Journal Article
  6. 6

    Purified yeast translational initiation factor eIF-3 is an RNA-binding protein complex that contains the PRT1 protein by Naranda, T. (University of California, Davis, CA.), MacMillan, S.E, Hershey, J.W.B

    Published in The Journal of biological chemistry (23-12-1994)
    “…Eukaryotic initiation factor-3 (eIF-3) plays a pivotal role in the initiation phase of protein synthesis where it promotes dissociation of 80 S ribosomes into…”
    Get full text
    Journal Article
  7. 7

    A peptide derived from an extracellular domain selectively inhibits receptor internalization: Target sequences on insulin and insulin-like growth factor I receptors by Naranda, Tatjana, Goldstein, Avram, Olsson, Lennart

    “…Certain peptides derived from the alpha1 domain of the major histocomapitbility class I antigen complex (MHC-I) inhibit receptor internalization. Receptors…”
    Get full text
    Journal Article
  8. 8

    Activation of erythropoietin receptor through a novel extracellular binding site by Naranda, Tatjana, Kaufman, R Ilene, Li, Jin, Wong, Kenneth, Boge, Annegret, Hallén, Dan, Fung, Kim Y C, Duncan, Mark W, Andersen, Niels, Goldstein, Avram, Olsson, Lennart

    Published in Endocrinology (Philadelphia) (01-06-2002)
    “…Activation of erythropoietin (EPO) receptor (EPOR) by a small peptide (ERP) was reported previously. ERP binds to a different receptor site than EPO, and…”
    Get full text
    Journal Article
  9. 9

    Activation of Erythropoietin Receptor through a Novel Extracellular Binding Site by Naranda, Tatjana, Kaufman, R. Ilene, Li, Jin, Wong, Kenneth, Boge, Annegret, Hallén, Dan, Fung, Kim Y. C, Duncan, Mark W, Andersen, Niels, Goldstein, Avram, Olsson, Lennart

    Published in Endocrinology (Philadelphia) (01-06-2002)
    “…Activation of erythropoietin (EPO) receptor (EPOR) by a small peptide (ERP) was reported previously. ERP binds to a different receptor site than EPO, and…”
    Get full text
    Journal Article
  10. 10

    The 39-kilodalton subunit of eukaryotic translation initiation factor 3 is essential for the complex's integrity and for cell viability in Saccharomyces cerevisiae by Naranda, Tatjana, Kainuma, Mami, MacMillan, Susan E., Hershey, John W. B.

    Published in Molecular and Cellular Biology (01-01-1997)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  11. 11

    GCD10, a translational repressor of GCN4, is the RNA-binding subunit of eukaryotic translation initiation factor-3 by Garcia-Barrio, M T, Naranda, T, Vazquez de Aldana, C R, Cuesta, R, Hinnebusch, A G, Hershey, J W, Tamame, M

    Published in Genes & development (15-07-1995)
    “…GCN4 mRNA is translated by a reinitiation mechanism involving four short upstream open reading frames (uORFs) in its leader sequence. Decreasing the activity…”
    Get full text
    Journal Article
  12. 12

    Two structural domains of initiation factor eIF-4B are involved in binding to RNA by NARANDA, T, STRONG, W. B, MENAYA, J, FABBRI, B. J, HERSHEY, J. W. B

    Published in The Journal of biological chemistry (20-05-1994)
    “…Translation initiation factor eIF-4B promotes the binding of mRNA to 40 S preinitiation complexes and together with eIF-4A possesses RNA helicase activity. To…”
    Get full text
    Journal Article
  13. 13

    Stable binding of the eukaryotic acidic phosphoproteins to the ribosome is not an absolute requirement for in vivo protein synthesis by REMACHA, M, SANTOS, C, BERMEJO, B, NARANDA, T, BALLESTA, J. P. G

    Published in The Journal of biological chemistry (15-06-1992)
    “…The genes encoding the four acidic ribosomal phosphoproteins have been inactivated in Saccharomyces cerevisae by recombination with truncated genes carrying…”
    Get full text
    Journal Article
  14. 14

    Phosphorylation Controls Binding of Acidic Proteins to the Ribosome by Naranda, Tatjana, Juan P. G. Ballesta

    “…The replacement of each one of the eight serine residues present in the amino acid sequence of the Saccharomyces cerevisiae acidic ribosomal phosphoprotein…”
    Get full text
    Journal Article
  15. 15

    Mutations in the NKXD consensus element indicate that GTP binds to the γ-subunit of translation initiation factor eIF2 by Naranda, Tatjana, Sirangelo, Ivana, Fabbri, Bradon J., Hershey, John W.B.

    Published in FEBS letters (25-09-1995)
    “…Initiation factor eIF2 binds GTP and promotes the binding of methionyl-tRNA to ribosomes. Biochemical and sequence evidence suggests that the GTP might bind to…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The activity-controlling phosphorylation site is not the same in the four acidic ribosomal proteins from Saccharomyces cerevisiae by Naranda, T, Remacha, M, Ballesta, J.P.G

    Published in The Journal of biological chemistry (05-02-1993)
    “…By using site-directed mutagenesis and chemical analysis of phosphopeptides, a unique phosphorylation site has been shown at serine 73 in the amino acid…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Effect of spermine on the efficiency and fidelity of the codon‐specific binding of tRNA to the ribosomes by NARANDA, Tatjana, KUČCN, Željko

    Published in European journal of biochemistry (15-06-1989)
    “…Binding of the yeast Tyr‐tRNA and Phe‐tRNA to the A site, and the binding of their acetyl derivatives to the P site of poly(U11,A)‐programmed Escherichia coli…”
    Get full text
    Journal Article
  20. 20